|Company - Telephone|
Products, Fields of specialty
|ProMining Therapeutics - (972).2.6509105|
Biopharmaceutical R&D focused on development of small-molecule drugs for treatment of cancer, inflammation, chronic pain, cardiovascular and viral diseases using CavitIIRx platform and SH3 domain-mediated protein interactions.
|Quark Pharmaceuticals - (972).8.9305111|
Genomics-based drug discovery and development. BiFAR platform for bioinformatics-based target gene selection. Current focus on cancer, fibrotic diseases, ischemic diseases, brain disorders, bone and cartilage disorders, diabetes.